Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
October 27, 2022
Consolidated Financial Results
for the Six Months Ended September 30, 2022
(Under Japanese GAAP)
Company name: | Taoka Chemical Co., Ltd | |
Listing: | Tokyo Stock Exchange | |
Securities code: | 4113 | |
URL: | https://www.taoka-chem.co.jp | |
Representative: | Yasuaki Sasaki, President | |
Inquiries: | Yasuhito Katsumoto, General Manager, Business Services Office | |
Telephone: | +81-6-7639-7400 | |
Scheduled date to file quarterly securities report: | November 10, 2022 | |
Scheduled date to commence dividend payments: | December 2, 2022 |
Preparation of supplementary material on quarterly financial results: None
Holding of quarterly financial results briefing: Yes (for institutional investors and analysts)
(Yen amounts are rounded down to millions, unless otherwise noted.)
1. Consolidated financial results for the six months ended September 30, 2022 (from April 1, 2022 to September 30, 2022)
(1) Consolidated operating results (cumulative) | (Percentages indicate year-on-year changes.) | ||||||||||||
Net income | |||||||||||||
Sales revenue | Operating income | Ordinary income | attributable to | ||||||||||
owners of the | |||||||||||||
parent | |||||||||||||
Six months ended | Millions of | % | Millions of | % | Millions of | % | Millions of | % | |||||
yen | yen | yen | yen | ||||||||||
September 30, 2022 | 15,264 | (9.4) | 249 | (86.4) | 279 | (85.0) | 191 | (85.7) | |||||
September 30, 2021 | 16,855 | 6.0 | 1,829 | 0.0 | 1,867 | 0.3 | 1,336 | 5.4 |
Note: Comprehensive income | For the six months ended September 30, 2022: ¥240 million [(81.9)%] | ||
For the six months ended September 30, 2021: ¥1,329 million [4.0%] | |||
Net income | Diluted net income | ||
per share | per share | ||
Six months ended | Yen | Yen | |
September 30, 2022 | 13.35 | - | |
September 30, 2021 | 93.25 | - |
Note: Effective on October 1, 2021, the Company split one common share into five shares. Net income per share was calculated under the assumption that this stock split was conducted at the beginning of the previous consolidated fiscal year.
(2) Consolidated financial position | ||||
Total assets | Net assets | Equity-to-asset | ||
ratio | ||||
As of | Millions of yen | Millions of yen | % | |
September 30, 2022 | 32,641 | 16,732 | 51.3 | |
March 31, 2022 | 32,417 | 16,749 | 51.7 |
Reference: Equity | |||||||||
As of September 30, 2022: | ¥16,732 million | ||||||||
As of March 31, 2022: | ¥16,749 million | ||||||||
2. Cash dividends | |||||||||
Annual dividends per share | |||||||||
First | Second | Third | Fiscal year- | Total | |||||
quarter-end | quarter-end | quarter-end | end | ||||||
Yen | Yen | Yen | Yen | Yen | |||||
Fiscal year ended | − | 90.00 | − | 18.00 | − | ||||
March 31, 2022 | |||||||||
Fiscal year ending | − | 18.00 | |||||||
March 31, 2023 | |||||||||
Fiscal year ending | |||||||||
March 31, 2023 | − | 9.00 | 27.00 | ||||||
(Forecast) | |||||||||
Note: Revisions to the forecasts of cash dividends most recently announced: Yes
For details of the revisions to the dividend forecasts, please refer to "Differences between Financial Forecasts and Actual Results for Six Months Ended September 30, 2022, and Revisions to Full-Year Financial Forecasts and Year-End Dividend Forecasts," disclosed on October 27, 2022.
Effective on October 1, 2021, the Company split one common share into five shares. The year-end dividend per share for the fiscal year ended March 31, 2022 is stated by taking into account the effect of the stock split, and the total annual dividend is stated as "−." When the effect of the stock split is taken into account, the second quarter-end dividend per share and annual dividend per share for the fiscal year ended March 31, 2022 will be ¥18.00 and ¥36.00, respectively.
3. Consolidated financial forecasts for the fiscal year ending March 31, 2023 (from April 1, 2022 to March 31, 2023)
(Percentages indicate year-on-year changes.)
Net income | Net | |||||||||
attributable to | ||||||||||
Sales revenue | Operating income | Ordinary income | income | |||||||
owners of the | ||||||||||
per share | ||||||||||
parent | ||||||||||
Millions of | % | Millions of | % | Millions of | % | Millions of | % | yen | ||
yen | yen | yen | yen | |||||||
Full year | 31,000 | (4.2) | 500 | (81.5) | 500 | (82.1) | 300 | (85.5) | 20.94 |
Note: Revisions to the forecasts of consolidated financial results most recently announced: Yes
For details of the revisions to the consolidated financial forecasts, please refer to "Differences between Financial Forecasts and Actual Results for Six Months Ended September 30, 2022, and Revisions to Full- Year Financial Forecasts and Year-End Dividend Forecasts," disclosed on October 27, 2022.
* Notes
- Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in the change in scope of consolidation): None
- Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: Yes
- Changes in accounting policies, changes in accounting estimates, and restatement
- Changes in accounting policies due to revisions to accounting standards and other regulations: None
- Changes in accounting policies due to other reasons: None
- Changes in accounting estimates: None
- Restatement: None
- Number of issued shares (common shares)
- Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2022 | 14,440,000 shares |
As of March 31, 2022 | 14,440,000 shares |
(ii) Number of treasury shares at the end of the period
As of September 30, 2022 | 111,140 shares |
As of March 31, 2022 | 111,140 shares |
- Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Six months ended September 30, 2022 | 14,328,860 shares |
Six months ended September 30, 2021 | 14,328,860 shares |
Note: Effective on October 1, 2021, the Company split one common share into five shares. The above numbers of shares were calculated under the assumption that this stock split was conducted at the beginning of the previous consolidated fiscal year.
- Quarterly financial results reports are exempt from quarterly review conducted by certified public accountants or an audit corporation.
-
Proper use of earnings forecasts, and other special matters (Caution regarding forward-looking statements and others)
The forward-looking statements, including financial forecasts, contained in this report are based on information currently available to the Company and certain assumptions deemed to be reasonable. Accordingly, they are not intended to be construed as assurance that they will be accomplished in the future. Note that actual results may differ materially from the forecasts for a number of reasons.
The Taoka Chemical Group's consolidated sales revenue for the six months ended September 30, 2022, decreased by ¥1,591 million compared with the same period of the previous fiscal year, to ¥15,264 million. The Group posted operating income of ¥249 million, ordinary income of ¥279 million and net income attributable to owners of the parent of ¥191 million.
The financial results of Taoka Chemical by business segment for the six month period were as follows:
Division | Six Months Ended | Six Months Ended | Change | ||||
September 30, 2021 | September 30, 2022 | ||||||
Millions of | Composition | Millions of | Composition | Millions of | Year-on-year | ||
yen | ratio (%) | yen | ratio (%) | yen | rate (%) | ||
Fine Chemicals | 9,996 | 59.3 | 7,343 | 48.1 | (2,652) | (26.5) | |
Functional Chemicals | 1,964 | 11.7 | 1,638 | 10.7 | (326) | (16.6) | |
Functional Polymers and | 4,604 | 27.3 | 5,981 | 39.2 | 1,376 | 29.9 | |
Additives | |||||||
Chemicals Segment | 16,566 | 98.3 | 14,963 | 98.0 | (1,602) | (9.7) | |
Others | 289 | 1.7 | 300 | 2.0 | 11 | 3.9 | |
Total | 16,855 | 100.0 | 15,264 | 100.0 | (1,591) | (9.4) | |
Chemicals Segment
Sales revenue of this segment was ¥14,963 million, a ¥1,602 million decrease compared to the same period of the previous fiscal year.
Fine Chemicals Division
Though shipments of agrochemical intermediates increased, shipments of monomers for optical resins decreased. As a result, the division sales revenue decreased by ¥2,652 million, to ¥7,343 million.
Functional Chemicals Division
Shipments of adhesives and rubber additives decreased. As a result, the division sales revenue decreased by ¥326 million to ¥1,638 million.
Functional Polymers and Additives Division
Though shipments of plasticizers and varnish decreased, their sales prices increased reflecting a steep rise in raw material prices. As a result, the division sales revenue increased by ¥1,376 million, to ¥5,981 million.
Others (Analytical Services)
Sales of evaluation of hazardous substances and asbestos analysis increased. As a result, the segment sales revenue increased by ¥11 million, to ¥300 million.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Taoka Chemical Co. Ltd. published this content on 27 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 October 2022 07:03:00 UTC.